FAKTOR OPTIONSSCHEIN - STAAR SURGICAL Share Price

Certificat

DE000PG4S7P8

Delayed Deutsche Boerse AG 09:20:32 18/06/2024 pm IST
0.63 EUR -10.00% Intraday chart for FAKTOR OPTIONSSCHEIN - STAAR SURGICAL
Current month+7.69%
1 month+18.64%
Date Price Change
18/24/18 0.63 -10.00%
17/24/17 0.7 +7.69%
14/24/14 0.65 +10.17%
13/24/13 0.59 -7.81%
12/24/12 0.64 -24.71%

Delayed Quote Deutsche Boerse AG

Last update June 18, 2024 at 09:20 pm IST

More quotes

Static data

Product typeProductos Exóticos
Buy / SellCALL
Underlying STAAR SURGICAL COMPANY
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PG4S7P
ISINDE000PG4S7P8
Date issued 24/10/2023
Strike 40.08 $
Maturity Unlimited
Parity 1 : 1
Emission price 10
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 19.02
Lowest since issue 0.31
Spread 0.03
Spread %4.48%

Company Profile

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.
Sector
-
More about the company

Ratings for STAAR Surgical Company

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: STAAR Surgical Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
40.08 USD
Average target price
51.68 USD
Spread / Average Target
+28.94%
Consensus